Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
1,672
NCT00333073
Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence
Phase: N/A
Role: Lead Sponsor
Start: Mar 31, 2006
Completion: May 31, 2010
NCT00407914
Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds
Start: Dec 31, 2006
Completion: Jul 31, 2009
NCT00629083
Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
Start: Apr 30, 2008
Completion: May 31, 2013
NCT03474653
LATITUDE An Observational Study of Patient Choice and the Urethral Bulking Agent, Bulkamid®
Role: Collaborator
Start: Jun 12, 2017
Completion: Jun 30, 2024
NCT04045431
Treatment of Knee Osteoarthritis With PAAG-OA
Start: May 15, 2019
Completion: Nov 30, 2026
NCT04179552
PAAG-OA Treatment for Knee Osteoarthritis
Start: Aug 21, 2019
Completion: Sep 19, 2024
NCT05057559
Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis
Start: Apr 21, 2021
Completion: Jul 1, 2028